diazooxonorleucine and Disease Exacerbation

diazooxonorleucine has been researched along with Disease Exacerbation in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Sun, L; Xin, Y; Yang, X; Yu, W; Yuan, S; Zhang, Q	1
Hammoud, DA; Maric, D; Miller, LH; Munasinghe, JP; Pierce, SK; Powell, JD; Prchalova, E; Riggle, BA; Schreiber-Stainthorp, W; Sinharay, S; Slusher, BS	1

Reviews

1 review(s) available for diazooxonorleucine and Disease Exacerbation

Article	Year
Targeting GLS1 to cancer therapy through glutamine metabolism. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2021, Volume: 23, Issue:11 Topics: Apoptosis; Benzophenanthridines; Cell Proliferation; Diazooxonorleucine; Disease Progression; Drug Resistance, Neoplasm; Genes, myc; Glutaminase; Glutamine; Humans; MicroRNAs; Neoplasm Proteins; Neoplasms; NF-kappa B; Oxidation-Reduction; Phosphates; Prognosis; Retinoblastoma Protein; Sulfides; Thiadiazoles	2021

Article

Year

Targeting GLS1 to cancer therapy through glutamine metabolism.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2021, Volume: 23, Issue:11

Topics: Apoptosis; Benzophenanthridines; Cell Proliferation; Diazooxonorleucine; Disease Progression; Drug Resistance, Neoplasm; Genes, myc; Glutaminase; Glutamine; Humans; MicroRNAs; Neoplasm Proteins; Neoplasms; NF-kappa B; Oxidation-Reduction; Phosphates; Prognosis; Retinoblastoma Protein; Sulfides; Thiadiazoles

2021

Other Studies

1 other study(ies) available for diazooxonorleucine and Disease Exacerbation

Article	Year
MRI demonstrates glutamine antagonist-mediated reversal of cerebral malaria pathology in mice. Proceedings of the National Academy of Sciences of the United States of America, 2018, 12-18, Volume: 115, Issue:51 Topics: Adult; Animals; Antimalarials; Biomarkers; Blood-Brain Barrier; Brain; Brain Edema; Child; Diazooxonorleucine; Disease Models, Animal; Disease Progression; Female; Glutamine; Humans; Magnetic Resonance Imaging; Malaria, Cerebral; Malaria, Falciparum; Mice; Mice, Inbred C57BL; Plasmodium falciparum	2018

Article

Year

MRI demonstrates glutamine antagonist-mediated reversal of cerebral malaria pathology in mice.

Proceedings of the National Academy of Sciences of the United States of America, 2018, 12-18, Volume: 115, Issue:51

Topics: Adult; Animals; Antimalarials; Biomarkers; Blood-Brain Barrier; Brain; Brain Edema; Child; Diazooxonorleucine; Disease Models, Animal; Disease Progression; Female; Glutamine; Humans; Magnetic Resonance Imaging; Malaria, Cerebral; Malaria, Falciparum; Mice; Mice, Inbred C57BL; Plasmodium falciparum

2018